tradingkey.logo

Alcon AG

ALC
81.150USD
+0.730+0.91%
Handelsschluss 01/29, 16:00ETKurse um 15 Minuten verzögert
40.14BMarktkapitalisierung
38.33KGV TTM

Alcon AG

81.150
+0.730+0.91%

mehr Informationen über Alcon AG Unternehmen

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

Alcon AG Informationen

BörsenkürzelALC
Name des UnternehmensAlcon AG
IPO-datumApr 09, 2019
CEOEndicott (David J)
Anzahl der mitarbeiter25599
WertpapierartOrdinary Share
GeschäftsjahresendeApr 09
AddresseRue Louis d'Affry 6
StadtFRIBOURG
BörseNASDAQ OMX NASDAQ Basic NYSE
LandSwitzerland
Postleitzahl1700
Telefon41589113800
Websitehttps://www.alcon.ch/
BörsenkürzelALC
IPO-datumApr 09, 2019
CEOEndicott (David J)

Führungskräfte von Alcon AG

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-25803.00%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+37205.00%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+3218.00%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-10011.00%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+2838.00%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+2982.00%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+2196.00%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+1584.00%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+1280.00%
Mr. F. Michael (Mike) Ball
Mr. F. Michael (Mike) Ball
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-25803.00%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+37205.00%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+3218.00%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-10011.00%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+2838.00%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+2982.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
745.00M
28.78%
Contact lenses
707.00M
27.31%
Ocular health
462.00M
17.84%
Implantables
432.00M
16.69%
Equipment/other
243.00M
9.39%
Nach RegionUSD
Name
Umsatz
Anteil
International
1.42B
54.92%
United States
1.17B
45.08%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
745.00M
28.78%
Contact lenses
707.00M
27.31%
Ocular health
462.00M
17.84%
Implantables
432.00M
16.69%
Equipment/other
243.00M
9.39%

Aktionärsstatistik

Aktualisiert: Thu, Nov 27
Aktualisiert: Thu, Nov 27
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.25%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
Andere
84.11%
Aktionäre
Aktionäre
Anteil
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.25%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
Andere
84.11%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
31.70%
Investment Advisor/Hedge Fund
25.00%
Bank and Trust
4.08%
Sovereign Wealth Fund
2.35%
Hedge Fund
2.09%
Research Firm
1.93%
Pension Fund
1.41%
Individual Investor
0.13%
Insurance Company
0.07%
Andere
31.24%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
1623
342.44M
72.26%
+507.76K
2025Q3
1664
342.40M
72.42%
-9.24M
2025Q2
1658
350.50M
70.82%
+3.47M
2025Q1
1649
340.47M
77.49%
-46.78M
2024Q4
1637
370.92M
68.31%
+36.10M
2024Q3
1614
334.31M
67.55%
+3.20M
2024Q2
1581
336.83M
74.41%
-28.77M
2024Q1
1567
336.16M
66.45%
+4.09M
2023Q4
1583
325.43M
67.42%
+1.37M
2023Q3
1565
323.23M
69.34%
-9.13M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.97M
4.2%
+321.27K
+1.56%
Sep 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
Aristotle Capital Management, LLC
10.71M
2.14%
-1.33M
-11.06%
Sep 30, 2025
T. Rowe Price Associates, Inc.
10.26M
2.05%
+3.27M
+46.89%
Sep 30, 2025
AKO Capital LLP
7.97M
1.6%
+260.96K
+3.38%
Sep 30, 2025
Zürcher Kantonalbank (Asset Management)
8.49M
1.7%
-648.99K
-7.10%
Sep 30, 2025
Fidelity Management & Research Company LLC
7.45M
1.49%
-2.76M
-27.02%
Sep 30, 2025
Select Equity Group, L.P.
6.73M
1.35%
-34.72K
-0.51%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Global X Aging Population ETF
2.36%
Franklin FTSE Switzerland ETF
2.28%
iShares MSCI Switzerland ETF
2.2%
First Trust Indxx Medical Devices ETF
2.06%
Running Oak Efficient Growth ETF
1.77%
Global X S&P Catholic Values Developed ex-US ETF
1.07%
JPMorgan BetaBuilders Europe ETF
0.59%
iShares Global Healthcare ETF
0.53%
ALPS O'Shares International Developed Quality Dividend ETF
0.45%
Wahed Dow Jones Islamic World ETF
0.44%
Mehr Anzeigen
Global X Aging Population ETF
Anteil2.36%
Franklin FTSE Switzerland ETF
Anteil2.28%
iShares MSCI Switzerland ETF
Anteil2.2%
First Trust Indxx Medical Devices ETF
Anteil2.06%
Running Oak Efficient Growth ETF
Anteil1.77%
Global X S&P Catholic Values Developed ex-US ETF
Anteil1.07%
JPMorgan BetaBuilders Europe ETF
Anteil0.59%
iShares Global Healthcare ETF
Anteil0.53%
ALPS O'Shares International Developed Quality Dividend ETF
Anteil0.45%
Wahed Dow Jones Islamic World ETF
Anteil0.44%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 400.00M USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI